FdaApplication
NDA 207793
Identifiers
- fda_app_no: NDA207793
Properties
| Property | Value |
|---|---|
| applicant_name | IPSEN BIOPHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2015-10-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ONIVYDE | IRINOTECAN HYDROCHLORIDE | EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML) | INJECTABLE, LIPOSOMAL;INTRAVENOUS |
1 product